Top Markets
Coin of the day
General Biologicals Corporation General Biologicals Corporation

General Biologicals Corporation

4117
Rank in Stocks #29238
General Biologicals Corporation (GBC) is a company dedicated to the research,... General Biologicals Corporation (GBC) is a company dedicated to the research, development, production, and global commercialization of in-vitro diagnostic (IVD) solutions, operating extensively both within Taiwan and internationally. The company's core diagnostic offerings include advanced ELISA and chemiluminescence immunoassays, molecular and cellular diagnostic platforms, and rapid point-of-care testing (POCT) systems. Its diverse portfolio further encompasses COVID-19 related solutions, digital pathology, and contract development manufacturing organization (CDMO) services. Additionally, GBC provides essential blood screening services for detecting hepatitis and HIV, alongside crucial biomaterials such as antibody preparations and human plasma. Venturing beyond diagnostics, the company also markets a line of oral care products under its proprietary 'oh care' brand. These diagnostic systems are primarily utilized by clinics and laboratories. Founded in 1973, General Biologicals Corporation is headquartered in Hsinchu City, Taiwan.
Share Price
$0.31640033
Market Cap
$22.25M
Change (1 day)
-3.40%
Change (1 year)
-36.80%
Country
TW
Trade General Biologicals Corporation (4117)

Category

Price of 4117 with the market cap of B
General Biologicals Corporation General Biologicals Corporation
4117
$0.31640033
Market Capitalization of General Biologicals Corporation(4117)
Market Cap: $22.25M
As of August 2026 General Biologicals Corporation has a market cap of $22.25M. This makes General Biologicals Corporation the world's 29238th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of General Biologicals Corporation from 2007 to 2026
4117 compared with Top 5 Most Popular stocks
Price of 4117 Asset B Mkt. of B Results
General Biologicals Corporation General Biologicals Corporation
$75,496.46 $22.25M
$5.309T +23,860,955.59%
General Biologicals Corporation General Biologicals Corporation
$66,168.33 $22.25M
$4.653T +20,912,751.83%
General Biologicals Corporation General Biologicals Corporation
$59,028.53 $22.25M
$4.151T +18,656,179.94%
General Biologicals Corporation General Biologicals Corporation
$50,942.93 $22.25M
$3.583T +16,100,682.31%
General Biologicals Corporation General Biologicals Corporation
$40,212.70 $22.25M
$2.828T +12,709,336.96%